全部

1·In-stent restenosis has been significantly reduced by utilization of drug eluting stents.

药物涂层支架的应用显著降低了支架内再狭窄的发生。

2·The cost of drug eluting stents per person and cost of each drug eluting stent in imported stent group were significantly higher than those of domestic stent group (P<0.001).

进口支架组人均置入支架总费用和单个支架费用均显著高于国产支架组（P<0.001）；

3·Objective to study the related factors and prognosis of rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

目的：探讨ST段抬高性心肌梗死患者经皮冠状动脉介入置入雷帕霉素药物洗脱支架内血栓形成的相关因素及预后。

4·Objective Compare drug-eluting stent (DES) to bare-metal stent(BMS) in prognosis on treating diffuse coronary lesions and analysis risk factor of treating complex and diffuse lesions in PCI.

目的比较冠心病患者弥漫病变采用药物洗脱支架和金属裸支架治疗的近期和远期预后，分析影响这类病变介入治疗预后的危险因素。

5·The implantation of a drug-eluting stent is one of the main methods for treating coronary heart disease, but the occurrence of thrombogenesis after implantation remains a problem.

药物洗脱支架置入是目前治疗冠心病的主要方式，但血栓形成仍是目前关注的主要问题。

6·This article reviews the clinical evidence and pathophysiological mechanisms of stent thrombosis of drug-eluting stent, especially the role of the stent itself in it.

现对药物涂层支架内血栓形成的相关临床证据和病理生理机制，特别是药物涂层支架本身在其中的作用进行综述。

7·Right now, we try to keep dual anti-platelet therapy going for up to one year in patients who have a drug-eluting stent because we are very concerned about the possibility of late-stent thrombosis.

目前，对于接受药物洗脱支架的患者，我们尝试维持双重抗血小板治疗在一年以上，因为我们非常关注晚期支架内血栓形成的可能性。

8·Attention has recently been focused on late stent thrombosis related to the use of drug-eluting stents.

但最近药物支架晚期血栓的问题倍受关注。

9·Conclusion Drug-eluting stent implantation can decrease the rate of restenosis significantly in coronary intervention.

结论药物涂层支架置入可显著降低冠脉介入术后再狭窄率。

10·OBJECTIVE: To understand the types and characteristics of anti-proliferative drug-eluting stent, and its effectiveness in clinical applications and problems to be solved.

目的：了解抗增殖作用药物涂层支架的种类和特点及其在临床应用中的有效性和亟待解决的问题。